Riverain Technologies Revenue and Competitors

Miamisburg, OH

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Riverain Technologies's estimated annual revenue is currently $14.1M per year.(i)
  • Riverain Technologies's estimated revenue per employee is $251,000

Employee Data

  • Riverain Technologies has 56 Employees.(i)
  • Riverain Technologies grew their employee count by 10% last year.

Riverain Technologies's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Science OfficerReveal Email/Phone
3
Chief Commercial Officer (CCO)Reveal Email/Phone
4
Chief Product OfficerReveal Email/Phone
5
Director SalesReveal Email/Phone
6
Sales Director - East ZoneReveal Email/Phone
7
Director Sales - Southern United StatesReveal Email/Phone
8
Director SalesReveal Email/Phone
9
Director Upstream MarketingReveal Email/Phone
10
Director Sales - Federal GovernmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$470.6M18751%N/AN/A
#2
$16.3M65-2%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M150%N/AN/A
#5
$21.1M844%N/AN/A
#6
$70M2798%N/AN/A
#7
$4M16-11%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$11.5M465%N/AN/A
#10
$8.8M3535%N/AN/A
Add Company

What Is Riverain Technologies?

Riverain Technologies is dedicated to thoracic imaging, providing software tools to aid clinicians in the efficient, effective early detection of lung disease. With Riverain's ClearRead applications, clinicians are empowered by tools that enable them to read faster and more effectively across the entire enterprise. ClearRead CT Suite Riverain’s ClearRead CT is the solution thoracic radiologists have been waiting for. ClearRead CT provides radiologists with a vessel suppressed CT series that removes the challenging vascular structure, enabling them to accurately detect actionable lung nodules sooner. ClearRead CT is the first detection tool cleared by the FDA for concurrent reading, allowing radiologists to read the ClearRead CT series during their initial read. This provides significant time savings when utilizing ClearRead CT. Additionally, ClearRead CT is designed for the detection of all nodule types, including solid, part-solid and ground glass nodules, making it the first FDA cleared system for automatic detection of non-solid lesions. The software is proven to reduce reading time by 26%, while simultaneously reducing the number of missed actionable nodules by 29%. ClearRead CT was designed to support rapid installation, with the ability to deploy across all CT device manufacturers, and to do so without requiring investment in additional hardware. • ClearRead CT | Vessel Suppress – removes the distracting vascular structure in a chest CT providing radiologists with an unobstructed view of actionable nodules. • ClearRead CT | Detect – provides measurement and characteristic data of detected regions helping radiologists read more quickly and efficiently. ClearRead X-ray Suite Riverain’s ClearRead X-ray Suite provides radiologists with the tools to get the most out of chest X-ray imaging. The enterprise capabilities of the applications in the ClearRead X-ray Suite make the technology a cost effective, universal solution for any facility. ClearRead X-ray is comprised of four software applications: Bone Suppression, Detect, Confirm, and Compare. Riverain’s foundational X-ray application, ClearRead Bone Suppression, suppresses all bone structures within the image to produce a soft tissue image. This enables radiologists to accurately detect important regions sooner. The additional three x-ray products use the bone suppression technique as a foundation, enabling images with CAD markings (Detect), line and tube enhancement for portables (Confirm), and a difference image highlighting what has changed over time (Compare). • ClearRead Bone Suppression – suppresses ribs and clavicles, providing a soft tissue image that allows radiologists to detect up to 17 % more lung nodules. • ClearRead Detect – identifies areas on a chest X-ray that may be lung cancer by placing a computer-aided detection (CAD) marking around the suspicious region, helping radiologists detect lung cancer up to 18 months sooner. • ClearRead Confirm – enhances lines and tubes on portable chest X-rays reducing the need for windowing and leveling, allowing radiologists to read up to 19% faster. • ClearRead Compare – allows radiologists to detect 1 in 10 previously missed emerging nodules by providing a difference image that shows what has changed between a prior and current chest X-ray.

keywords:N/A

N/A

Total Funding

56

Number of Employees

$14.1M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M572%N/A
#2
$12.1M592%N/A
#3
$8.2M6334%N/A
#4
$15.8M657%N/A
#5
$8.9M68-6%N/A